Mami Kurosaki

A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)

Hiroshige Yoshioka, K. Azuma, Nobuyuki Yamamoto et al. · Annals of Oncology · 2015 · 117 citations · Full text

Medicine, Oncology, Pharmacology +16

Purification, cDNA Cloning, and Tissue Distribution of Bovine Liver Aldehyde Oxidase

Marco LiCalzi, Carlo Raviolo, Elena Ghibaudi et al. · Journal of Biological Chemistry · 1995 · 107 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells

Mineko Terao, Maddalena Fratelli, Mami Kurosaki et al. · Journal of Biological Chemistry · 2010 · 92 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Cellular and molecular determinants of all‐trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression

Floriana Centritto, Gabriela Paroni, Marco Bolis et al. · EMBO Molecular Medicine · 2015 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +15

Tissue- and cell-specific expression of mouse xanthine oxidoreductase gene <i>in vivo</i>: regulation by bacterial lipopolysaccharide

Mami Kurosaki, Marco Li Calzi, Eugenio Scanziani et al. · Biochemical Journal · 1995 · 79 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13